Article
Smad4/DPC4.
Journal of clinical pathology - 1 Aug 2018
McCarthy Aoife J, Chetty Runjan
Abstract excerpt
Smad4 or DPC4 belongs to a family of signal transduction proteins that are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to transforming growth factor beta (TGF-β) signaling via several pathways. The gene acts as a tumour suppressor gene and inactivation of smad4/DPC4 is best recognised in pancreatic cancer. However, smad4/DPC4 is also mutated in other conditions and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
